• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关和非靶点滞留与靶向区域 [F]MK6240 tau PET 纵向定量的关联。

The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [F]MK6240 Tau PET in Target Regions.

机构信息

McGill University, Montreal, Quebec, Canada.

McGill University Research Center for Studies in Aging, Montreal, Quebec, Canada.

出版信息

J Nucl Med. 2023 Mar;64(3):452-459. doi: 10.2967/jnumed.122.264434. Epub 2022 Nov 17.

DOI:10.2967/jnumed.122.264434
PMID:36396455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10071794/
Abstract

6-(fluoro-F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([F]MK6240) tau PET tracer quantifies the brain tau neurofibrillary tangle load in Alzheimer disease. The aims of our study were to test the stability of common reference region estimates in the cerebellum over time and across diagnoses and evaluate the effects of age-related and off-target retention on the longitudinal quantification of [F]MK6240 in target regions. We assessed reference, target, age-related, and off-target regions in 125 individuals across the aging and Alzheimer disease spectrum with longitudinal [F]MK6240 SUVs and SUV ratios (SUVRs) (mean ± SD, 2.25 ± 0.40 y of follow-up). We obtained SUVR from meninges, exhibiting frequent off-target retention with [F]MK6240. Additionally, we compared tracer uptake between 37 cognitively unimpaired young (CUY) (mean age, 23.41 ± 3.33 y) and 27 cognitively unimpaired older (CU) adults (amyloid-β-negative and tau-negative, 58.50 ± 9.01 y) to identify possible nonvisually apparent, age-related signal. Two-tailed testing and Pearson correlation testing were used to determine the difference between groups and associations between changes in region uptake, respectively. Inferior cerebellar gray matter SUV did not differ on the basis of diagnosis and amyloid-β status, cross-sectionally and over time. [F]MK6240 uptake significantly differed between CUY and CU adults in the putamen or pallidum (affecting ∼75% of the region) and in the Braak II region (affecting ∼35%). Changes in meningeal and putamen or pallidum SUVRs did not significantly differ from zero, nor did they vary across diagnostic groups. We did not observe significant correlations between longitudinal changes in age-related or meningeal off-target retention and changes in target regions, whereas changes in all target regions were strongly correlated. Inferior cerebellar gray matter was similar across diagnostic groups cross-sectionally and stable over time and thus was deemed a suitable reference region for quantification. Despite not being visually perceptible, [F]MK6240 has age-related retention in subcortical regions, at a much lower magnitude but topographically colocalized with significant off-target signal of the first-generation tau tracers. The lack of correlation between changes in age-related or meningeal and target retention suggests little influence of possible off-target signals on longitudinal tracer quantification. Nevertheless, the age-related retention in the Braak II region needs to be further investigated. Future postmortem studies should elucidate the source of the newly reported age-related [F]MK6240 signal, and in vivo studies should further explore its impact on tracer quantification.

摘要

6-(氟代-F)-3-(1H-吡咯并[2,3-c]吡啶-1-基)异喹啉-5-胺([F]MK6240)tau PET 示踪剂定量测定阿尔茨海默病患者脑中的 tau 神经纤维缠结负荷。我们研究的目的是测试小脑内常见参考区域估计值随时间和诊断的稳定性,并评估与年龄相关的和非靶区保留对目标区域内[F]MK6240的纵向定量的影响。我们在具有纵向[F]MK6240 SUV 和 SUV 比值(SUVR)(平均±SD,2.25±0.40 年随访)的 125 名个体中评估了参考、目标、与年龄相关和非靶区。我们从脑膜中获得 SUVR,脑膜中经常存在[F]MK6240 的非靶区保留。此外,我们比较了 37 名认知正常的年轻(CUY)(平均年龄,23.41±3.33 岁)和 27 名认知正常的年长(CU)成年人(β-淀粉样蛋白阴性和 tau 阴性,58.50±9.01 岁)之间的示踪剂摄取,以确定可能存在非视觉性、与年龄相关的信号。采用双尾 t 检验和 Pearson 相关检验分别确定组间差异和区域摄取变化之间的相关性。小脑下 Gray Matter 的 SUV 无论是在横断面上还是随时间变化,均不基于诊断和淀粉样蛋白-β 状态而存在差异。[F]MK6240 在 CUY 和 CU 成年人的壳核或苍白球(影响约 75%的区域)和 Braak II 区域(影响约 35%)之间的摄取显著不同。脑膜和壳核或苍白球 SUVR 的变化均与零无显著差异,且在不同诊断组之间无差异。我们没有观察到与年龄相关或脑膜非靶区保留的纵向变化与目标区域的变化之间存在显著相关性,而所有目标区域的变化均具有很强的相关性。小脑下 Gray Matter 在横断面上在不同诊断组之间相似,且随时间稳定,因此被认为是定量的合适参考区。尽管肉眼不可见,但[F]MK6240 在皮质下区域存在与年龄相关的保留,其程度较低,但在拓扑上与第一代 tau 示踪剂的显著非靶区信号重合。年龄相关或脑膜与目标保留的变化之间缺乏相关性表明,可能的非靶区信号对纵向示踪剂定量的影响很小。然而,Braak II 区域的与年龄相关的保留仍需进一步研究。未来的尸检研究应阐明新报道的与年龄相关的[F]MK6240 信号的来源,体内研究应进一步探讨其对示踪剂定量的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/99f9309e4864/jnumed.122.264434f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/e0c1e5db83d2/jnumed.122.264434f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/aab985d0a16b/jnumed.122.264434f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/17d11c95f348/jnumed.122.264434f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/99f9309e4864/jnumed.122.264434f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/e0c1e5db83d2/jnumed.122.264434f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/aab985d0a16b/jnumed.122.264434f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/17d11c95f348/jnumed.122.264434f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84eb/10071794/99f9309e4864/jnumed.122.264434f4.jpg

相似文献

1
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [F]MK6240 Tau PET in Target Regions.年龄相关和非靶点滞留与靶向区域 [F]MK6240 tau PET 纵向定量的关联。
J Nucl Med. 2023 Mar;64(3):452-459. doi: 10.2967/jnumed.122.264434. Epub 2022 Nov 17.
2
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
3
Sex differences in off-target binding using tau positron emission tomography.使用tau 正电子发射断层扫描观察药物的脱靶结合的性别差异。
Neuroimage Clin. 2021;31:102708. doi: 10.1016/j.nicl.2021.102708. Epub 2021 May 29.
4
Optimizing quantification of MK6240 tau PET in unimpaired older adults.优化未受损老年人群中 MK6240 tau PET 的定量分析。
Neuroimage. 2023 Jan;265:119761. doi: 10.1016/j.neuroimage.2022.119761. Epub 2022 Nov 28.
5
Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden.18F-MK6240和18F-氟代tau示踪剂在年龄、简易精神状态检查表(MMSE)和脑β-淀粉样蛋白负荷匹配人群中的tau成像横断面和纵向比较
J Prev Alzheimers Dis. 2023;10(2):251-258. doi: 10.14283/jpad.2023.17.
6
Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [F]-AV-1451 PET data.常见参考区域对横断面和纵向[F]-AV-1451 PET 数据中区域 tau 模式的影响。
Neuroimage. 2021 Nov;243:118553. doi: 10.1016/j.neuroimage.2021.118553. Epub 2021 Sep 3.
7
Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL F-MK6240 PET study.衰老过程中和阿尔茨海默病连续体中区域 tau 积累的速率:AIBL F-MK6240 PET 研究。
EBioMedicine. 2023 Feb;88:104450. doi: 10.1016/j.ebiom.2023.104450. Epub 2023 Jan 27.
8
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.18F-氟托西匹 PET 与阿尔茨海默病和其他神经退行性疾病的尸检比较。
Brain. 2020 Dec 5;143(11):3477-3494. doi: 10.1093/brain/awaa276.
9
Partial volume correction in longitudinal tau PET studies: is it really needed?纵向tau蛋白正电子发射断层扫描(PET)研究中的部分容积校正:真的有必要吗?
Neuroimage. 2024 Apr 1;289:120537. doi: 10.1016/j.neuroimage.2024.120537. Epub 2024 Feb 15.
10
Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles.阿尔茨海默病患者和老年对照组的脑成像研究,使用 F-MK-6240,一种针对神经纤维缠结的 PET 示踪剂。
J Nucl Med. 2019 Jan;60(1):107-114. doi: 10.2967/jnumed.118.208215. Epub 2018 Jun 7.

引用本文的文献

1
Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers.α-突触核蛋白生物标志物的现状及对α-突触核蛋白PET示踪剂的需求
Cells. 2025 Aug 18;14(16):1272. doi: 10.3390/cells14161272.
2
Test-retest performance of [ F]MK-6240 tau burden and relative delivery indices in cognitively normal older subjects using PET/MRI.使用PET/MRI对认知正常的老年受试者进行[¹⁸F]MK-6240 tau负荷和相对递送指数的重测性能。
Imaging Neurosci (Camb). 2024 Dec 20;2. doi: 10.1162/imag_a_00402. eCollection 2024.
3
Evaluating the effect of extra-cerebral off-target binding in [F-18]MK6240 PET scans in early-stage Alzheimer's disease.

本文引用的文献

1
Biomarker modeling of Alzheimer's disease using PET-based Braak staging.使用基于 PET 的 Braak 分期对阿尔茨海默病的生物标志物建模。
Nat Aging. 2022 Jun;2(6):526-535. doi: 10.1038/s43587-022-00204-0. Epub 2022 Apr 25.
2
18F-MK-6240 tau-PET in genetic frontotemporal dementia.18F-MK-6240 tau-PET 用于遗传性额颞叶痴呆。
Brain. 2022 Jun 3;145(5):1763-1772. doi: 10.1093/brain/awab392.
3
Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.18F-MK-6240 tau 缠结的纵向积累遵循 Braak 分期。
评估[F-18]MK6240正电子发射断层显像(PET)扫描中脑外非靶向结合在早期阿尔茨海默病中的作用。
Imaging Neurosci (Camb). 2024 Apr 18;2. doi: 10.1162/imag_a_00135. eCollection 2024.
4
Comparison of visual and analytic methods of Alzheimer's disease pathologic staging.阿尔茨海默病病理分期的视觉与分析方法比较
Alzheimers Dement. 2025 Jul;21(7):e70520. doi: 10.1002/alz.70520.
5
[I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus-Subiculum and Evaluation of Drug Effects.[I]用于tau成像的IPPI:对死后人类阿尔茨海默病海马-下托的结合研究及药物效果评估。
Synapse. 2025 Jul;79(4):e70024. doi: 10.1002/syn.70024.
6
Exploring the origins of frequent tau-PET signal in vermal and adjacent regions.探索蚓部及相邻区域tau正电子发射断层扫描(PET)信号频繁出现的起源。
Eur J Nucl Med Mol Imaging. 2025 Mar 18. doi: 10.1007/s00259-025-07199-x.
7
Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1-indoles as Tauopathy Positron Emission Tomography Radiotracers.2-(杂芳基-环烷基)-1-吲哚作为tau蛋白病正电子发射断层显像剂的构效关系及评价
J Med Chem. 2025 Mar 27;68(6):6462-6492. doi: 10.1021/acs.jmedchem.4c02988. Epub 2025 Mar 11.
8
Increased between-network connectivity: A risk factor for tau elevation and disease progression.增加网络间连通性:tau 升高和疾病进展的风险因素。
Neurosci Lett. 2024 Sep 25;840:137943. doi: 10.1016/j.neulet.2024.137943. Epub 2024 Aug 15.
9
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease.个性化全脑神经群体模型揭示阿尔茨海默病中 Aβ 和 tau 过度兴奋的综合影响。
Commun Biol. 2024 May 4;7(1):528. doi: 10.1038/s42003-024-06217-2.
10
APOE ε4 is associated with decreased synaptic density in cognitively impaired participants.载脂蛋白 E ε4 与认知障碍参与者的突触密度降低有关。
Alzheimers Dement. 2024 May;20(5):3157-3166. doi: 10.1002/alz.13775. Epub 2024 Mar 13.
Brain. 2021 Dec 16;144(11):3517-3528. doi: 10.1093/brain/awab248.
4
Sex differences in off-target binding using tau positron emission tomography.使用tau 正电子发射断层扫描观察药物的脱靶结合的性别差异。
Neuroimage Clin. 2021;31:102708. doi: 10.1016/j.nicl.2021.102708. Epub 2021 May 29.
5
Direct Comparison of the Tau PET Tracers F-Flortaucipir and F-MK-6240 in Human Subjects.在人体受试者中 Tau PET 示踪剂 F-Flortaucipir 和 F-MK-6240 的直接比较。
J Nucl Med. 2022 Jan;63(1):108-116. doi: 10.2967/jnumed.120.254961. Epub 2021 Apr 16.
6
Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex, ε4, and Cognitive Impairment.生物定义的阿尔茨海默病与年龄、性别、ε4 及认知障碍的关系频率。
Neurology. 2021 Feb 16;96(7):e975-e985. doi: 10.1212/WNL.0000000000011416. Epub 2020 Dec 21.
7
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019.未能证明 aducanumab 的疗效:Biogen 报告的 EMERGE 和 ENGAGE 试验分析,2019 年 12 月。
Alzheimers Dement. 2021 Apr;17(4):696-701. doi: 10.1002/alz.12213. Epub 2020 Nov 1.
8
Determining Amyloid-β Positivity Using F-AZD4694 PET Imaging.使用 F-AZD4694 PET 成像测定淀粉样蛋白-β阳性。
J Nucl Med. 2021 Feb;62(2):247-252. doi: 10.2967/jnumed.120.245209. Epub 2020 Jul 31.
9
18F-MK-6240 PET for early and late detection of neurofibrillary tangles.18F-MK-6240 PET 用于早期和晚期检测神经纤维缠结。
Brain. 2020 Sep 1;143(9):2818-2830. doi: 10.1093/brain/awaa180.
10
Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.原发性年龄相关性 tau 病(PART):解决衰老大脑中神经元 tau 病变化的谱。
Curr Neurol Neurosci Rep. 2020 Jul 14;20(9):39. doi: 10.1007/s11910-020-01063-1.